Skip to main content
. 2021 Nov 11;13(11):1912. doi: 10.3390/pharmaceutics13111912

Figure 7.

Figure 7

EPR spectra obtained with 5-SASL (1) and 16-SASL (2), inserted into nanoparticles; SLN and NLC4 (4% of AO) prepared with CP (a) and MM (b).